BioHealth News Archive
Maryland Stem Cell Research Commission Announces $6.6 Million in Stem Cell Program Awards | TEDCO
The Maryland Stem Cell Research Commission (Commission) has approved funding to its second round of 2019 recipients for a total of $6,622,673.63. The Commission…
Read More
Baltimore Start Up NextStep Robotics Receives $600,000 in Second Funding Round – NextStep Robotics
NextStep Robotics Inc., an early-stage company that has developed a personalized robotic therapy to help treat foot drop in recovering stroke patients, announces the…
Read More
Interview: Susan Hockfield on the Dawn of the Biotech Revolution
AS A CHILD, Susan Hockfield took apart anything she got her hands on to figure out how it worked. One time it was a…
Read More
NIST Director: Improving Tech Transfer of Federally Funded R&D Key to U.S. Competitiveness
The U.S. government invests a significant amount of money to further research and technology innovation. In 2017, the federal government invested approximately $150 billion…
Read More
Amazon, JBG submit HQ2 development plans – Washington Business Journal
The submission to Arlington County ends months of speculation. {iframe}https://www.bizjournals.com/washington/news/2019/05/16/amazon-reveals-development-plans-for-hq2.html{/iframe}
Read More
BARDA will procure Emergent BioSolutions’ AV7909 anthrax vaccine in Strategic National Stockpile – Homeland Preparedness News
The Biomedical Advanced Research and Development Authority (BARDA) will begin procuring Emergent BioSolutions’ anthrax vaccine into the Strategic National Stockpile (SNS) to strengthen U.S.…
Read More
THE ANGEL MARKET IN 2018 MORE ANGELS INVESTING IN MORE DEALS AT LOWER VALUATIONS
The angel investor market in 2018 experienced an increase in market participation in more companies, albeit at smaller amounts, according to the Center for…
Read More
Venture capital funds jump into the Opportunity Zone game – Business Insider
Venture capital firms are starting to launch and raise funds to invest in companies located in designated Opportunity Zones, where investors can get ..…
Read More
FDA Approves New Combination Therapy for Type 2 Diabetes – Endocrinology Advisor
The Food and Drug Administration (FDA) has approved Qternmet XR (AstraZeneca) as an adjunct to diet and exercise to improve glycemic control in adults…
Read More
Biotech’s top 10 money raisers of 2018 – FierceBiotech
If 2017 was a banner year for biotech venture capital, 2018 blew it out of the water. Last year, private biotech companies reeled in…
Read More
Beltsville’s NextCure closes IPO – Washington Business Journal
The net proceeds from the IPO, along with NextCure's cash on hand, will largely be used to drive its lead product, NC318, through clinical…
Read More
How Venture Capital is Investing in Gene Therapy – Bloomberg
Alexis Borisy, Third Rock Ventures partner, discusses the fund's biotech investment strategy on "Bloomberg Technology {iframe}https://www.bloomberg.com/news/videos/2019-05-13/how-venture-capital-is-investing-in-gene-therapy-video{/iframe}
Read More
Refueling vaccine innovation | McKinsey
Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical and complex…
Read More
Viela Bio Presents Pivotal Study Results of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder in a Plenary Session at the American Academy of Neurology Annual Meeting | Viela Bio
Viela Bio today announced results from a pivotal study of its anti-CD19 monoclonal antibody, inebilizumab, in patients with neuromyelitis optica spectrum disorder (NMOSD) —…
Read More
Q&A: Children’s National CEO talks about research ambitions for partnership with JLABS | FierceHealthcare
It's not often a piece of property with existing research facilities in a perfect location comes on the market. So when a 12-acre portion of…
Read More